Lodoxamide ethyl

CAS No. 53882-13-6

Lodoxamide ethyl( —— )

Catalog No. M36189 CAS No. 53882-13-6

lodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 120 In Stock
10MG 177 In Stock
25MG 334 In Stock
50MG 435 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lodoxamide ethyl
  • Note
    Research use only, not for human use.
  • Brief Description
    lodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
  • Description
    lodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    53882-13-6
  • Formula Weight
    367.74
  • Molecular Formula
    C15H14ClN3O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(C(OCC)=O)=O)C1=C(Cl)C(NC(C(OCC)=O)=O)=CC(C#N)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chalcone b

    Chalcone is an aromatic ketone that forms the central core for a variety of important biological compounds which are known collectively as chalcones.

  • Methyl anthranilate

    Methyl anthranilate is a natural product. Methyl anthranilate is a novel quorum sensing inhibitor and anti-biofilm agent against Aeromonas sobria

  • JI130

    JI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.